New York, United States , Nov. 28, 2023 (GLOBE NEWSWIRE) -- The Global Diagnostic Electrocardiograph (ECG) Market Size is to Grow from USD 7.56 Billion in 2022 to USD 13.88 Billion by 2032, at a ...

Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Diagnostic Electrocardiograph (ECG) Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's ...

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...

By type, the diagnostic ECG market is further segmented into portable, wearable, and implantable ECG devices. In 2024, the portable ECG devices segment accounted for the largest market share, driven ...

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at ...

HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

PharmEasy-backed Thyrocare has bought a 100% stake in Chennai-based diagnostic service provider Think Health in an all-cash deal that enables it to enter the at-home ECG services and insurance ...

Communicating concerns about nonspecific changes on ECG Exercise caution when a patient presents with acute chest pain. The ability to explain the situation as clearly as possible is essential.